Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-097487
Filing Date
2024-09-05
Accepted
2024-09-05 19:52:10
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423453-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2423453-1_4seq1.xml 4 8151
  Complete submission text file 0001104659-24-097487.txt   9980
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GRITSTONE ONCOLOGY, INC. 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address
Bellemin Jean-Marc (Reporting) CIK: 0001754253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 241282670